Immune-based strategies to achieve HIV remission are increasingly focusing on ways to boost the body’s ability to control persistent viral reservoirs. Among these approaches, natural killer (NK) cells could be genetically engineered to enhance their ability to recognize and eliminate HIV-infected cells and overcome viral evasion mechanisms. Researchers discussed this emerging strategy at the 26th International AIDS Conference (AIDS 2026).

Scientists in the U.K. have used genome mining to identify bacterial species capable of producing novel polyene antifungal compounds that are both more effective and have a more benign side effect profile than approved polyenes such as amphotericin and nystatin.

Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological imprint. At the 26th International AIDS Conference (AIDS 2026), researchers reported persistent abnormalities affecting the gut, cardiovascular system, metabolism and immune function despite effective viral control.